Clinical Trial Update: Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on biomarker-based neoadjuvant strategies for locally advanced resectable esophageal squamous cell carcinoma, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING